Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Centessa Pharmaceuticals plc | 3,931,818 | 3,931,818 | 0 | $35.50M | $62.87M | 45.36% | +$27.37M |
| Tectonic Therapeutic, Inc.(TECX) | 0 | 1,028,674 | +1,028,674 | $0 | $31.17M | 22.49% | +$31.17M |
| Kyverna Therapeutics, Inc.(KYTX) | 4,523,924 | 4,523,924 | 0 | $33.93M | $22.12M | 15.96% | -$11.81M |
| Dyne Therapeutics, Inc.(DYN) | 407,499 | 407,499 | 0 | $14.38M | $14.64M | 10.56% | +$256.7K |
| Allogene Therapeutics, Inc. | 1,798,163 | 1,798,163 | 0 | $4.19M | $5.03M | 3.63% | +$845.1K |
| Kronos Bio, Inc. | 2,765,314 | 2,765,314 | 0 | $3.43M | $2.77M | 2.00% | -$663.7K |